长期插管后拔管患者持续吸气肌无力常见,初始诊断后12天测最大吸气压力可早期预测
这项在瑞士五家医院开展的前瞻性观察研究纳入69例机械通气≥7天、计划拔管后48小时内诊断吸气肌无力(MIP≤30 cmH2O)的ICU患者,追踪急性期住院期间MIP和MRC评分变化。研究完成时43%(30例)患者持续存在吸气肌无力,中位MIP为22 [13-24] cmH2O,而无持续无力者MIP为44 [36-64] cmH2O。单变量logistic回归显示持续吸气肌无力与女性、纳入前儿茶酚胺使用时长、第12天MIP、第12天MRC评分及纳入至第12天MIP变化正相关,与呼吸系统合并症负相关。作者结论认为长期机械通气后持续吸气肌无力在急性期住院至出院期间常见,纳入后第12天MIP及其变化与持续无力强相关。
要点
- 机械通气≥7天拔管后48小时内MIP≤30 cmH2O的患者中,43%(30/69)在急性期住院结束时仍存在持续吸气肌无力(MIP≤30 cmH2O),中位MIP 22 [13-24] cmH2O。
- 无持续吸气肌无力者研究完成时中位MIP为44 [36-64] cmH2O,与持续无力组22 [13-24] cmH2O形成对比。
- 单变量分析中,纳入后第12天MIP、第12天MRC评分及纳入至第12天MIP变化与持续吸气肌无力正相关。
- 女性、纳入前儿茶酚胺使用时长与持续吸气肌无力正相关;呼吸系统合并症与其负相关。
- 随机森林模型确定纳入后第12天为MIP预测持续吸气肌无力的最佳时间点。
适用人群与场景
- ICU中机械通气≥7天、计划拔管后48小时内诊断吸气肌无力(MIP≤30 cmH2O)并完成研究的患者,共69例(48男,21女),来自瑞士五家医院。
诊断标准与关键阈值
- 吸气肌无力(IMW)定义为最大吸气压力(MIP)≤30 cmH2O。
- 持续IMW定义为研究完成时MIP≤30 cmH2O。
研究设计与关键结果
- 研究为探索性前瞻性观察研究,在瑞士五家医院开展,纳入69例机械通气≥7天、计划拔管后48小时内诊断IMW(MIP≤30 cmH2O)的ICU患者。
- 研究完成时持续IMW见于30例(43%),中位MIP为22 [13-24] cmH2O;无持续IMW者MIP为44 [36-64] cmH2O。
- 单变量logistic回归显示持续IMW与女性、纳入前儿茶酚胺使用时长、第12天MIP、第12天MRC评分及纳入至第12天MIP变化正相关;呼吸系统合并症负相关。
- 随机森林模型识别纳入后第12天为MIP预测持续IMW的最佳时间点。
证据类型、等级与局限
- 证据类型:探索性前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对机械通气≥7天拔管后48小时内MIP≤30 cmH2O的患者,可在纳入后第12天复测MIP及其较纳入时的变化,以协助识别急性期住院结束时仍可能存在持续吸气肌无力的患者。
- 作者认为纳入后第12天MIP及其变化与持续IMW强相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Prolonged mechanical ventilation (MV) frequently results in inspiratory and peripheral muscle weakness, impairing recovery. These conditions can be identified at the bedside using respectively Maximal Inspiratory Pressure (MIP) measurement and Medical Research Council (MRC) score. This study investigated the evolution over the acute-care hospital stay of MIP and MRC score in patients with documented post-extubation inspiratory muscle weakness (IMW), defined as MIP ≤ 30 cmH2O, and looked for the factors associated with persistent IMW at the end of the acute care hospital stay.
METHOD: This exploratory prospective observational study was conducted across five Swiss hospitals. Patients in the Intensive Care Unit (ICU) who were extubated after ≥ 7 days of MV, with IMW diagnosed within 48 h post planned extubation, were included. Patients' characteristics and ICU-related factors were recorded throughout the acute care stay as were MIP and MRC score. ICU-acquired weakness (ICU-AW) recorded in the medical file, ICU readmission, reintubation, and hospital mortality were also documented. Descriptive statistics and linear interpolation for missing MIP data were applied, and associations with persistent IMW (MIP ≤ 30 cmH2O) at study completion were explored using univariable logistic regression. The optimal timepoint for predicting persistent IMW using MIP was identified using a random forest model.
RESULTS: Sixty-nine patients (48 men, 21 women) completed the study. At study completion, persistent IMW was observed in 30 patients (43%), with a median MIP of 22 [13-24] cmH2O. MIP was of 44 [36-64] in patients without persistent IMW. Persistent IMW was positively associated in univariable logistic regression with female sex, duration of catecholamine use until inclusion, MIP at day 12, MRC score at day 12 and changes in MIP from inclusion to day 12. The presence of respiratory comorbidities was negatively associated with persistent IMW.
CONCLUSION: Persistent IMW following prolonged MV is frequent throughout the acute care stay and until acute care hospital discharge. The MIP measured at day 12 after inclusion, as well as its change from inclusion to day 12, were strongly associated with persistent IMW.
参考来源
- Oestreicher V, Hennemann M, Hilfiker R, et al. Persistent inspiratory muscle weakness among extubated patients after prolonged intubation is frequent and can be predicted early by maximal inspiratory pressure measured 12 days after its initial diagnosis: a prospective observational study. Crit Care. 2025. PMID: 41204221. doi:10.1186/s13054-025-05718-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。